Home Tags Pharma

Tag: Pharma

Astellas Pharma Inc., Beijing Minhai Biotechnology Co., Ltd – Industry News...

The global “Herpes Zoste Drug market” research report highlights the need for the up-to-date market data for the business management that will offer...

Global Pertussis Vaccine Market 2019 – Astellas Pharma, Minhai Biotechnology, Wuhan...

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell...

Intec Pharma Ltd (NTEC) Receives $12.70 Average PT from Analysts

Intec Pharma Ltd (NASDAQ:NTEC) has been given a consensus rating of “Buy” by the eight brokerages that are...

Taiho Pharma, Cullinan Oncology join forces on EGFR drug for lung...

Taiho Pharmaceutical and Cullinan Oncology have inked a pact to develop the former’s EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor for lung...

Chutes & Ladders—Ex-Sanofi executive to head up translational medicine at LEO...

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word—or the...

Ex-Sanofi executive to head up translational medicine at LEO Pharma

LEO Pharma has hired on Thomas Hultsch as its new head of translational medicine. Hultsch will build LEO Pharma’s translational medicine presence in...

Comparing of ERYTECH Pharma S.A. (ERYP) and Unity Biotechnology Inc. (NASDAQ:UBX)

We are contrasting ERYTECH Pharma S.A. (NASDAQ:ERYP) and Unity Biotechnology Inc. (NASDAQ:UBX) on their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional...

This computer program makes pharma patents airtight — ScienceDaily

Routes to making life-saving medications and other pharmaceutical compounds are among the most carefully protected trade secrets in global industry. Building on recent...

aTyr Pharma Inc (LIFE) Receives Average Recommendation of “Hold” from Brokerages

Shares of aTyr Pharma Inc (NASDAQ:LIFE) have been assigned an average recommendation of “Hold” from the six analysts...

Gilead’s clinical research VP moves to U.S.-China NASH startup Terns Pharma

Gilead’s vice president of clinical research, Erin Quirk, M.D., is joining the NASH and cancer-focused Terns Pharmaceuticals as its new chief medical officer. The...

MOST POPULAR

HOT NEWS